3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
8
Melanoma
6
Neoplasm Metastasis
5
Thyroid Neoplasms
4
Thyroid Cancer, Papillary
4
Leukemia, Hairy Cell
4
Carcinoma, Non-Small-Cell Lung
4
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Thyroid Carcinoma, Anaplastic
2
Skin Neoplasms
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Hematologic Neoplasms
2
Glioma
2
Colorectal Neoplasms
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Thyroid cancer, follicular
1
Skin Diseases
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Noonan syndrome 3
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Interventions
pembrolizumab
6
Injections
6
senaparib
4
toripalimab
3
tislelizumab
3
Bevacizumab
3
sintilimab
2
Technetium
2
Specimen Handling
2
Nivolumab
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Blood Specimen Collection
2
zimberelimab
1
tumor-cells apoptosis factor, human
1
tazemetostat
1
spartalizumab
1
sacituzumab govitecan
1
rucaparib
1
osimertinib
1
olaparib
1
etoposide phosphate
1
enzalutamide
1
envafolimab
1
cemiplimab
1
cedazuridine
1
atezolizumab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
Vemurafenib
×
1 year
×
Clear all
No trials found.